SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Neuland Laboratories - Quaterly Results

29 Oct 2021 Evaluate
The company witnessed a 6.82% growth in the revenue at Rs. 2578.48 millions for the quarter ended September 2021 as compared to Rs. 2413.93 millions during the year-ago period.Net profit declined -4.75% to Rs. 203.26 millions from Rs. 213.40 millions.Operating profit for the quarter ended September 2021 rose to 430.75 millions as compared to 413.66 millions of corresponding quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 2578.48 2413.93 6.82 4587.35 4468.17 2.67 9369.13 7627.11 22.84
Other Income 2.87 6.06 -52.64 23.43 13.03 79.82 160.95 38.86 314.18
PBIDT 430.75 413.66 4.13 707.33 757.99 -6.68 1625.39 1053.44 54.29
Interest 35.60 35.12 1.37 74.03 88.81 -16.64 178.98 215.71 -17.03
PBDT 395.15 378.54 4.39 633.30 669.18 -5.36 1446.41 837.73 72.66
Depreciation 119.82 92.69 29.27 238.10 181.30 31.33 396.79 312.76 26.87
PBT 275.33 285.85 -3.68 395.20 487.88 -19.00 1049.62 524.97 99.94
TAX 72.07 72.45 -0.52 105.46 123.92 -14.90 246.67 366.16 -32.63
Deferred Tax 15.84 37.66 -57.94 15.97 89.13 -82.08 121.84 366.16 -66.72
PAT 203.26 213.40 -4.75 289.74 363.96 -20.39 802.95 158.81 405.60
Equity 129.01 129.01 0.00 129.01 129.01 0.00 129.01 129.01 0.00
PBIDTM(%) 16.71 17.14 -2.51 15.42 16.96 -9.11 17.35 13.81 25.61

Neuland Laboratories Share Price

14998.70 346.20 (2.36%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.20
Dr. Reddys Lab 1322.95
Cipla 1309.90
Zydus Lifesciences 891.65
Lupin 2303.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×